FCN-338
Product Specifications
CAS Number
2248046-39-9
Target
Bcl-2 Family
Related Pathways
Apoptosis
Bioactivity
FCN-338 (LOXO-338) is an orally active and selective Bcl-2 inhibitor, exhibiting an IC50 of 4.5 nM for the Bcl-2/BAK interaction. It effectively suppresses tumor growth in mouse models of follicular lymphoma (FL), acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL) xenografts without causing significant weight loss. FCN-338 demonstrates broad-spectrum anticancer activity, making it suitable for treating FL, chronic lymphocytic leukemia (CLL) /small lymphocytic leukemia (SLL), AML, and ALL.
Smiles
N(=O)(=O)C1=C2C(=CC(S(NC(=O)C3=C(OC=4C=C5C(=NC4)NC=C5)C=C(C=C3)N6CCN(CC7=C(CC(C)(C)CC7)C8=CC=C(Cl)C=C8)CC6)(=O)=O)=C1)OC[C@H](CC9=CC=CC=C9)N2
Molecular Formula
C48H48ClN7O7S
Molecular Weight
902.46
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Purified Anti-Mouse CD54 Antibody[YN1/1.7.4]](https://cdn.genprice.uk/products/763/68dd14c4061270361e7d7185/imageurl/e-ab-f1018a.webp)
![Purified Anti-Human CD58 Antibody[TS2/9.1]](https://cdn.genprice.uk/products/763/68dd14c4061270361e7d7155/imageurl/e-ab-f1068a.webp)
